Extraordinary bladder clots.
The patient with hematuria and clot retention who has an abnormality in urokinase-plasmin production or coagulopathy may have extraordinary clots. An understanding of the underlying disease and pathophysiology of clot formation will enable the urologist to better evaluate and treat this type of patient. Aberrations in urokinase-plasmin production or consumption occur in many disease states that may not be recognized generally.
D000328:Adult; D000368:Aged; D001777:Blood Coagulation; D005260:Female; D005341:Fibrinolysin / Q000378:metabolism; D006417:Hematuria / Q000150:complications* / Q000378:metabolism; D006801:Humans; D008297:Male; D013927:Thrombosis / Q000150:complications* / Q000378:metabolism; D001748:Urinary Bladder Neck Obstruction / Q000209:etiology*; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator